Janney Montgomery Scott LLC Sangamo Therapeutics, Inc Transaction History

Janney Montgomery Scott LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$4.27 - $6.39 $109,311 - $163,584	-25,600 Reduced 58.52%	18,145 $89,000
Q2 2022 Aug 03, 2022	SELL	$3.28 - $6.21 $37,392 - $70,794	-11,400 Reduced 20.67%	43,745 $179,000
Q1 2022 May 04, 2022	SELL	$5.23 - $7.82 $42,493 - $63,537	-8,125 Reduced 12.84%	55,145 $320,000
Q4 2021 Jan 27, 2022	SELL	$7.29 - $10.97 $13,122 - $19,746	-1,800 Reduced 2.77%	63,270 $475,000
Q3 2021 Oct 29, 2021	BUY	$9.01 - $12.01 $586,280 - $781,490	65,070 New	65,070 $586,000
Q1 2020 Apr 30, 2020	SELL	$5.05 - $8.85 $52,181 - $91,447	-10,333 Closed	0 $0
Q3 2019 Oct 29, 2019	SELL	$9.05 - $12.22 $407 - $549	-45 Reduced 0.43%	10,333 $94,000
Q2 2019 Jul 29, 2019	SELL	$8.75 - $13.03 $4,812 - $7,166	-550 Reduced 5.03%	10,378 $112,000
Q1 2019 Apr 30, 2019	SELL	$7.72 - $12.81 $772 - $1,281	-100 Reduced 0.91%	10,928 $104,000
Q2 2018 Jul 24, 2018	SELL	$13.9 - $19.8 $2,085 - $2,970	-150 Reduced 1.34%	11,028 $157,000
Q1 2018 Apr 19, 2018	SELL	$16.7 - $26.35 $5,845 - $9,222	-350 Reduced 3.04%	11,178 $212,000
Q3 2017 Nov 15, 2017	BUY	$8.4 - $15.0 $96,835 - $172,920	11,528	11,528 $173,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.